4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-058292
Chief Executive Officer sold 4,400 shares at an average $13.59 ($59,774)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2017-10-26 | Sale | −2,200 | $13.57 | $29,854 | 426,378 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2017-10-27 | Sale | −2,200 | $13.60 | $29,920 | 424,178 | I: show line 2 in the form |
| Open-market sales · 4,400 sh · avg $13.59 · $59,774 | |||||||
Loading xslF345X03/doc4.xml…